---
title: Digital Adherence Program_Ganfort maintenance
description: General education and support on treatment knowledge, medication use, and precautions for use, adverse effects and interactions with other medicines.
---

[![ma_logo_horizontal_full_white_bg](https://www.mymedadvisor.com/hubfs/ma_logo_horizontal_full_white_bg.svg "ma_logo_horizontal_full_white_bg")](http://mymedadvisor.com)

# Ganfort**®**/Ganfort**®**PF (bimatolprost/timolol)

Digital Adherence Program

Program overview

This sponsored program aims to provide education and support to patients prescribed Ganfort/Ganfort PF eye drops for the treatment of glaucoma.

Patients will receive a series of 9 messages over 10 months aimed at improving their quality use of medicines, medication adherence and treatment outcomes.

When?

This program was launched in May 2022.

For which patients?

Messages will be delivered via the app or SMS to patients currently prescribed Ganfort eye drops who have completed the first Ganfort Digital Adherence Program. 

[Click here to view a sample of the messages](https://www.mymedadvisor.com/hubfs/GANFORT_Maintenance%20DAP%20Messages.pdf?hsLang=en)

![Ganfort maintenance](https://www.mymedadvisor.com/hs-fs/hubfs/Ganfort%20maintenance.png?width=244&name=Ganfort%20maintenance.png "Ganfort maintenance")

© 2026 MedAdvisor International Pty Ltd